PURPOSE: Corneal confocal microscopy is emerging as a clinical tool to evaluate the development and progression of diabetic neuropathy. The purpose of these studies was to characterize the changes in corneal sensitivity and innervation in a rat model of type 2 diabetes in relation to standard peripheral neuropathy endpoints. Assessment of diabetes-induced changes in corneal innervation and sensitivity in animal models will be important for determining the usefulness of corneal markers for preclinical studies to test potential new treatments for diabetic neuropathy. METHODS: High-fat/low-dose streptozotocin diabetic rats were used to examine diabetes-induced changes in standard diabetic neuropathy endpoints and innervation of the cornea using confocal microscopy, corneal sensitivity using a Cochet-Bonnet esthesiometer, and vascular reactivity of the posterior ciliary artery. RESULTS: Compared with age-matched control rats, the induction of hyperglycemia in rats fed high-fat diets caused a decrease in nerve conduction velocity, thermal hypoalgesia, and intraepidermal nerve fiber profiles. In the cornea there was a decrease in corneal nerve fiber length and sensitivity. In addition, vascular relaxation in response to acetylcholine was decreased in the posterior ciliary artery. CONCLUSIONS: These studies suggest that in a type 2 diabetic rat model, changes in corneal nerve innervation and sensitivity occur that are consistent with changes seen in diabetic patients. Corneal sensitivity and innervation may be valuable endpoints for examining the potential treatments of diabetic neuropathy in preclinical studies.
PURPOSE: Corneal confocal microscopy is emerging as a clinical tool to evaluate the development and progression of diabetic neuropathy. The purpose of these studies was to characterize the changes in corneal sensitivity and innervation in a rat model of type 2 diabetes in relation to standard peripheral neuropathy endpoints. Assessment of diabetes-induced changes in corneal innervation and sensitivity in animal models will be important for determining the usefulness of corneal markers for preclinical studies to test potential new treatments for diabetic neuropathy. METHODS: High-fat/low-dose streptozotocindiabeticrats were used to examine diabetes-induced changes in standard diabetic neuropathy endpoints and innervation of the cornea using confocal microscopy, corneal sensitivity using a Cochet-Bonnet esthesiometer, and vascular reactivity of the posterior ciliary artery. RESULTS: Compared with age-matched control rats, the induction of hyperglycemia in rats fed high-fat diets caused a decrease in nerve conduction velocity, thermal hypoalgesia, and intraepidermal nerve fiber profiles. In the cornea there was a decrease in corneal nerve fiber length and sensitivity. In addition, vascular relaxation in response to acetylcholine was decreased in the posterior ciliary artery. CONCLUSIONS: These studies suggest that in a type 2 diabeticrat model, changes in corneal nerve innervation and sensitivity occur that are consistent with changes seen in diabeticpatients. Corneal sensitivity and innervation may be valuable endpoints for examining the potential treatments of diabetic neuropathy in preclinical studies.
Authors: Nathan Efron; Katie Edwards; Nicola Roper; Nicola Pritchard; Geoff P Sampson; Ayda M Shahidi; Dimitrios Vagenas; Anthony Russell; Jim Graham; Mohammad A Dabbah; Rayaz A Malik Journal: Eye Contact Lens Date: 2010-09 Impact factor: 2.018
Authors: Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Brian Dake; Mark A Yorek Journal: Eur J Pharmacol Date: 2010-10-30 Impact factor: 4.432
Authors: R A Malik; P Kallinikos; C A Abbott; C H M van Schie; P Morgan; N Efron; A J M Boulton Journal: Diabetologia Date: 2003-05-09 Impact factor: 10.122
Authors: Mitra Tavakoli; Cristian Quattrini; Caroline Abbott; Panagiotis Kallinikos; Andrew Marshall; Joanne Finnigan; Philip Morgan; Nathan Efron; Andrew J M Boulton; Rayaz A Malik Journal: Diabetes Care Date: 2010-04-30 Impact factor: 19.112
Authors: Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Donald D Lund; Mark A Yorek Journal: Obesity (Silver Spring) Date: 2008-01 Impact factor: 5.002
Authors: Irina G Obrosova; Fei Li; Omorodola I Abatan; Mark A Forsell; Katalin Komjáti; Pal Pacher; Csaba Szabó; Martin J Stevens Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Matthew S Yorek; Alexander Obrosov; Hanna Shevalye; Sergey Lupachyk; Matthew M Harper; Randy H Kardon; Mark A Yorek Journal: J Peripher Nerv Syst Date: 2014-09 Impact factor: 3.494
Authors: Matthew S Yorek; Alexander Obrosov; Hanna Shevalye; Amey Holmes; Matthew M Harper; Randy H Kardon; Mark A Yorek Journal: J Peripher Nerv Syst Date: 2015-03 Impact factor: 3.494
Authors: Yangyang Zhang; Nan Gao; Lin Wu; Patrick S Y Lee; Rao Me; Chenyang Dai; Lixin Xie; Fu-Shin X Yu Journal: Diabetes Date: 2020-04-28 Impact factor: 9.461
Authors: Hanna Shevalye; Matthew S Yorek; Lawrence J Coppey; Amey Holmes; Matthew M Harper; Randy H Kardon; Mark A Yorek Journal: J Neurophysiol Date: 2015-04-29 Impact factor: 2.714